Balantidiasis Treatment Market Research Report - Global forecast till 2023

1. Balantidiasis Treatment Market Global Opportunity, Size, Top Key Players, Developments Research in Clinical Manifestations and Business Insights 2019 - 2023 Balantidiasis Treatment and Diagnosis Industry Synopsis: Balantidiasis is a disease caused by the bacterium Balantidium coli which mainly affects the large intestine. The disease spreads through fecal-oral route due to the contamination of food and water by the feces of pig or human. Improper sanitary conditions and unsafe drinking water are important aspects for the spread of the diseases. Rising prevalence of gastrointestinal disorders, increasing number of patients and availability of treatment of balantidiasis drives the growth of the market. Additionally, the lack of hygiene and sanitation in the rural areas of developing countries is one of the many factors which affect the spread of this disease. Furthermore, rising awareness about the diseases transmitted through fecal- oral route influences the market growth. Competition among existing market players restrict the entry of new players. The global Balantidiasis Treatment Market is expected to grow at a CAGR of 2.1% during the forecast period. Avail FREE Sample at: https://www.marketresearchfuture.com/sample_request/4725 The market is driven by the increasing prevalence of communicable diseases in rural areas for developing countries. In addition, increasing research and development activities, technological advancements to identify the causes and risk factors for transmission of infectious agents and developing new solutions to minimize patient exposure is another major driver, fuelling the global market growth. Competitive Analysis: Some of the key players in the global market are – •Pfizer (U.S.) •Abbott (U.S.) •GlaxoSmithKline plc. (U.K) •BD (U.S.) •Sandoz International GmbH (Germany) •Amneal Pharmaceuticals LLC. (U.S.) •Akorn Inc. (U.S.) •PharmaDerm A division of Fougera Pharmaceuticals Inc. (U.S.). Market Research Future

2. Segmental Analysis: The global Balantidiasis Treatment Market is segmented on the basis of diagnosis, treatment, and end user. On the basis of diagnosis, the market is segmented into stool examination, sigmoidoscopy, biopsy, and others. On the basis of treatment, the market is segmented into antibiotics, appendectomy, and others. Antibiotics segment is further divided into tetracycline, metronidazole, and others. On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, and others. Intended Audience • • • • • • Drug Manufacturers Drug Suppliers Medical Research Laboratories Research and Development (R&D) Companies Market Research and Consulting Service Providers Potential Investors Brows Complete Detailed Research Report at https://www.marketresearchfuture.com/reports/balantidiasis-market-4725 Regional Analysis: The market is found to be steady in Americas. Emphasis on healthy lifestyle and prevention of communicable diseases also influence the growth of the market. The prevalence of the disease is found to the higher rural South America than North American countries. In Europe, the prevalence of balantidiasis is found to be low which is attributed to stringent regulations governing the manufacturing of food products and low prevalence of gastrointestinal diseases. In Asia Pacific, the prevalence of balantidiasis is found increasing steadily as a result of increasing prevalence of colitis, chronic diarrhea, and, deep intestinal ulcerations, poor healthcare system, and availability of treatment options for various gastrointestinal diseases. According to the data from GLOBOCAN, in 2012, the age-standardized rate (ASR) of incidence of gastrointestinal diseases in Asia Pacific was 15.8 and mortality was 11.7 per 100,000. According to World Health Organization (WHO), the geriatric population in China in the year 2013 was 22.6 million which is expected to show a massive growth to 90.4 million in 2050. Market Research Future

3. In the Middle East & Africa, gastrointestinal diseases are a major cause of disability. The infection is mainly acquired due to ingestion of food and water contaminated by cysts. About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future